Ulcerative Colitis
Ulcerative Colitis
Ulcerative Colitis
DEFINITION
a chronic disease of the large intestine, also known as the colon, in which the
lining of the colon becomes inflamed and develops tiny open sores, or ulcers,
that produce pus and mucus which can cause abdominal discomfort and frequent
emptying of the colon
The result of an abnormal response by your body's immune system.
*Normally, the cells and proteins that make up the immune system protect you
from infection. In people with IBD, however, the immune system mistakes food,
bacteria, and other materials in the intestine for foreign or invading substances.
When this happens, the body sends white blood cells into the lining of the
intestines, where they produce chronic inflammation and ulcerations.
INCIDENCE
The annual incidence of ulcerative colitis is between 1 to 10 cases per 100,000 people,
depending on the region studied. The peak age-specific incidence occurs near 20
years, and a second smaller peak occurs near age 50 years. The prevalence of
ulcerative colitis ranges from 10 to 70 per 100,000 people, but some North American
studies have shown prevalence as high as 200 per 100,000 people. In the United
States, males and females are equally affected, but both whites and Ashkenazi Jews
are at much higher risk of developing inflammatory bowel disease than the general
population. Ulcerative colitis patients are most often never smokers or non-smokers,
with no more than 10% being current cigarette smokers. Worldwide, ulcerative colitis
cases are concentrated in North America, Europe, and Australia, and a north-south
gradient exists, with higher incidence rates in higher latitudes. For unknown reasons, a
history of appendectomy is protective against the development of ulcerative colitis.
In a given year, 48% of people with ulcerative colitis are in remission, 30% have mild
disease activity, 20% have moderate disease activity, 1 to 2% have severe disease.
Seventy percent of patients who have active disease in a given year will have another
episode of active disease in the following year. Only 30% of those in remission in a
given year will have active disease in the following year. The longer a person with
ulcerative colitis remains in remission, the less likely he or she is to experience a flareup of the disease in the following year.
ETIOLOGY
Although considerable progress has been made in IBD research, investigators do not
yet know what causes this disease.
30% of all patients with ulcerative colitis, the illness begins as ulcerative proctitis
Bowel inflammation is limited to the rectum.
Milder form due its limited extent (usually < 6 inches of the rectum)
It is associated with fewer complications and offers a better outlook than more
widespread disease.
2.Proctosigmoiditis
Affects the rectum and the sigmoid colon
Symptoms include bloody diarrhea, cramps, and a constant feeling of the need to
pass stool, known as tenesmus.
Moderate pain on the lower left side of the abdomen may occur in active disease.
3.Left-sided Colitis
Begins at the rectum and extends as far as a bend in the colon near the spleen
called the splenic flexure.
Symptoms include loss of appetite, weight loss, diarrhea, severe pain on the left
side of the abdomen, and bleeding.
4.Pan-ulcerative (total) Colitis
Affects the entire colon
Symptoms include diarrhea, severe abdominal pain, cramps, and extensive
weight loss.
Potentially serious complications include massive bleeding and acute dilation of
the colon (toxic megacolon), which may lead to an opening in the bowel wall that
may require surgery.
Ulcerative colitis may also cause additional symptoms such as:
joint pain
joint swelling
nausea
vomiting
skin ulcers
mouth sores
COMPLICATIONS
Sepsis
Severe dehydration
PATHOPHYSIOLOGY
DIA
Blood tests: A blood test involves drawing blood. A lab technologist will analyze the
blood sample. A doctor may use blood tests to check for anemia, infection and
inflammation.
Stool tests: A stool test is the analysis of a sample of stool. It is used to check for
blood, bacteria and parasites. It can also help rule out GI disorders.
Colonoscopy: This exam allows your doctor to view your entire colon using a thin,
flexible, lighted tube with an attached camera. It can show irritated and swollen
tissue, ulcers, and abnormal growths such as polypsextra pieces of tissue that
grow on the inner lining of the intestine. If the gastroenterologist suspects ulcerative
colitis, he or she will biopsy the patient's colon and rectum. A biopsy is a procedure
that involves taking small pieces of tissue for examination with a microscope.
Flexible sigmoidoscopy: Flexible sigmoidoscopy is a test that uses a flexible,
narrow tube with a light and tiny camera on one end, called a scope, to look inside
the rectum, the sigmoid colon, and sometimes the descending colon. The doctor will
look for signs of bowel diseases and conditions such as irritated and swollen tissue,
ulcers, and polyps. If your colon is severely inflamed, your doctor may perform this
test instead of a full colonoscopy.
X-ray: If you have severe symptoms, your doctor may use a standard X-ray of your
abdominal area to rule out serious complications, such as a perforated colon.
CT scan: A CT scan of your abdomen or pelvis may be performed if your doctor
suspects a complication from ulcerative colitis or inflammation of the small intestine.
A CT scan may also reveal how much of the colon is inflamed.
Chromoendoscopy: Chromoendoscopy is a technique of spraying a blue liquid dye
during the colonoscopy in order to increase the ability of the endoscopist specialist
to detect slight changes in the lining of your intestine. The technique may identify
early or flat polyps which can be biopsied or removed. It is common to have blue
bowel movements for a short time following this procedure.
Treatment
The primary goal in treating ulcerative colitis is to help patients regulate their immune
system better.
Medical Management
Aminosalicylates (5-ASA)
Work at the level of the lining of the GI tract to decrease inflammation
Work best in the colon and are not particularly effective if the disease is limited to
the small intestine
Corticosteroids
Nonspecifically suppress the immune system and are used to treat moderate to
severely active ulcerative colitis. (By "nonspecifically," we mean that these drugs
do not target specific parts of the immune system that play a role in inflammation,
but rather, that they suppress the entire immune response.)
These drugs have significant short- and long-term side effects and should not be
used as a maintenance medication.
Immunomodulators
Modulates or suppresses the bodys immune system response so it cannot
cause ongoing inflammation
Antibiotics
Biologic Therapies
These therapies represent the latest treatment class used for people suffering
from moderate-to-severe ulcerative colitis.
The antibodies used for biologic therapy have been developed to bind and
interfere with the inflammatory process in the disease.
Anti-diarrheal medications
Pain relievers
Iron supplements
If you have chronic intestinal bleeding, you may develop iron deficiency anemia
and be given iron supplements.
Surgical Management
1.Proctocolectomy with ileostomy
A proctocolectomy is surgery to remove a patient's entire colon and rectum.
An ileostomy is a stoma, or opening in the abdomen, that a surgeon creates from a part
of the ileumthe last section of the small intestine. The surgeon brings the end of the
ileum through an opening in the patient's abdomen and attaches it to the skin, creating
an opening outside of the patient's body. The stoma most often is located in the lower
part of the patient's abdomen, just below the beltline.
People who have this type of surgery will have the ileostomy for the rest of their lives.
2.Proctocolectomy and ileoanal reservoir
An ileoanal reservoir is an internal pouch made from the patient's ileum. This surgery is
a common alternative to an ileostomy and does not have a permanent stoma. Ileoanal
reservoir is also known as a J-pouch, a pelvic pouch, or an ileoanal pouch anastomosis.
The ileoanal reservoir connects the ileum to the anus. The surgeon preserves the outer
muscles of the patient's rectum during the proctocolectomy. Next, the surgeon creates
the ileal pouch and attaches it to the end of the rectum. Waste is stored in the pouch
and passes through the anus.
After surgery, bowel movements may be more frequent and watery than before the
procedure. People may have fecal incontinencethe accidental passing of solid or
liquid stool or mucus from the rectum. Medications can be used to control pouch
function. Women may be infertile following the surgery.
Nursing Management
1.Acute Pain
Cleanse rectal area with mild soap and water or wipes after each stool and
provide skin care.
Weigh daily.
Encourage bed rest and limit activity during acute phase of illness.
Observe for excessively dry skin and mucous membranes, decreased skin
turgor, slowed capillary refill.